FDA Inspection
Bell Pharmaceuticals, IncBell Pharmaceuticals, Inc – FDA Inspection, Jun 18, 2025
Record Details
This FDA Inspection record concerns Bell Pharmaceuticals, Inc, with an inspection on June 18, 2025, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · 1926ee2f-7dde-4b69-842d-0d7262eb1ed9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1271571
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.103Actual vs. theoretical yields not determined
- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.22(a)Approve or reject components, products
- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bell Pharmaceuticals, Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 6, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 20, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 5, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 12, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 15, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bell Pharmaceuticals, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.